FDA Approves Rezzayo

FDA Approves Rezzayo

FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis SAN DIEGO & PARSIPPANY, N.J.–(BUSINESS WIRE)– March 22, 2023 — Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced that the U.S. Food and…

Read More